Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00683644 · ClinicalTrials.gov registry record · Phase 2

Zinc to Treat Tinnitus in the Elderly

A Phase 2 study of Tinnitus, sponsored by University of Iowa.

Completed
Registry status
Phase 2
Development phase
116
Enrollment target
1
Study location

NCT00683644 is a Phase 2 study of Tinnitus that has completed, run by University of Iowa. The registered enrollment target is 116 participants, below the 12,615-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00683644, a Phase 2 study of Tinnitus, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
Phase 2
Development phase
116 participants
Enrollment target
1
Study location

Study Summary

There is widespread belief and some evidence to indicate that zinc can successfully treat tinnitus. Zinc deficiency is more likely to occur in the elderly . The primary objective of this study is to establish the effectiveness of zinc for the treatment of tinnitus in individuals 60 years of age and older. Subjects will be randomly assigned to either receive zinc daily or a placebo. After 4 months and a 1-month wash-out, the subjects will be crossed over to the other group.

Conditions Studied

Interventions

  • DRUG Zinc
  • DRUG Placebo oral capsule

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2008-01
Est. Completion 2011-12
Phase Phase 2

Sponsor

University of Iowa

228 total trials

What the Registry Record Tells You About NCT00683644

The ClinicalTrials.gov registry entry for NCT00683644 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,615-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 2 interventions - of which Zinc is the first listed.

NCT00683644 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT00683644 about?

NCT00683644 is a clinical study titled "Zinc to Treat Tinnitus in the Elderly". There is widespread belief and some evidence to indicate that zinc can successfully treat tinnitus. Zinc deficiency is more likely to occur in the elderly . The primary objective of this study is to establish the effectiveness of zinc for the treatment of tinnitus in individuals 60 years of age and ...

What is the current status of trial NCT00683644?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 116 participants. The study started on 2008-01. Estimated completion is 2011-12.

What conditions does trial NCT00683644 study?

This clinical trial studies the following conditions: Tinnitus.

What interventions are being tested in trial NCT00683644?

The interventions under investigation include: Zinc (DRUG), Placebo oral capsule (DRUG).

Who is sponsoring clinical trial NCT00683644?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00683644 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tinnitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.